About Orfenix
Built to close the gap
between academic discovery
and patient access.

Orfenix brings together the development, regulatory, commercial and operational expertise needed to move promising academic therapies forward.

Why Orfenix exists ↘
?

More promising therapies should make it beyond academia.

Why Orfenix exists

Strong science does not automatically create a route to patients.

Universities and academic medical centres generate promising therapeutic discoveries, but many reach a point where scientific progress alone is no longer enough.

Moving forward requires development strategy, regulatory and clinical planning, funding, partnerships and a workable business structure. Orfenix brings those elements together and keeps patient access and affordability part of the programme from the start.

Expertise behind the model

Development needs more than one discipline. Orfenix brings together the expertise needed to structure, fund and advance academic therapies towards patients.

01

Medicine & clinical development

Translating scientific evidence into a clinically relevant development strategy, with clear next studies, endpoints and decision points.

Our partners

Erasmus MC
Amsterdam UMC
Gador
Ofichem Group
Avivia
UMC Utrecht
Leiden University Medical Center
Kidnie
Losan Pharma
Worldwide Clinical Trials
Uniklinikum Erlangen
Radboudumc
Hersenstichting
Tiofarma
CHDR
University of Groningen
Nierstichting
RARE-NL
Nomion Medicines
Starodub
01 ↗
Contact the right
Orfenix expert
02 ↗
Explore how the
Orfenix model works